Multifunctional HER2-Antibody conjugated polymeric nanocarrier-based drug delivery system for multi-drug-resistant breast cancer therapy

ACS Applied Materials and Interfaces

Volumn 6, Issue 9, 2014, Pages 6469-6480

  Vivek, Raju ^a   Thangam, Ramar ^a,b   Nipunbabu, Varukattu ^a   Rejeeth, Chandrababu ^a   Sivasubramanian, Srinivasan ^b   Gunasekaran, Palani ^b   Muthuchelian, Krishnasamy ^d   Kannan, Soundarapandian ^a,c  

^a BHARATHIAR UNIVERSITY   (India)

^b King Institute of Preventive Medicine and Research   (India)

^c PERIYAR UNIVERSITY   (India)

^d MADURAI KAMARAJ UNIVERSITY   (India)

Author keywords

antibody conjugated nanocarrier; biodegradable polymers; breast cancer therapy; drug delivery systems (DDS); multidrug resistance (MDR); tamoxifen

Indexed keywords

ANTIBODIES; BIODEGRADABLE POLYMERS; CELL DEATH; COPOLYMERS; DISEASES; DRUG DELIVERY; DRUG DOSAGE; DRUG PRODUCTS; DYNAMIC LIGHT SCATTERING; ENZYME INHIBITION; FOURIER TRANSFORM INFRARED SPECTROSCOPY; MEDICAL NANOTECHNOLOGY; MOLECULAR BIOLOGY; ONCOLOGY; TRANSMISSION ELECTRON MICROSCOPY;

BREAST CANCER; DRUG DELIVERY SYSTEM; MULTIDRUG RESISTANCE; NANOCARRIERS; TAMOXIFEN;

CONJUGATED POLYMERS;

DRUG CARRIER; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; NANOMATERIAL; POLYMER;

BREAST NEOPLASMS; CHEMISTRY; DRUG RESISTANCE; HUMAN; IMMUNOLOGY; MULTIDRUG RESISTANCE; TRANSMISSION ELECTRON MICROSCOPY;

BREAST NEOPLASMS; DRUG CARRIERS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOSTRUCTURES; POLYMERS; RECEPTOR, ERBB-2;

EID: 84900851915     PISSN: 19448244     EISSN: 19448252     Source Type: Journal    
DOI: 10.1021/am406012g     Document Type: Conference Paper

References (47)

1. Feng, S. S. Chemotherapeutic Engineering: Concept, Feasibility, Safety and Prospect-A Tribute to Shu Chien's 80th Birthday Cell. Mol. Bioeng. 2011, 4, 708-716
2. Colotta, F. Anticancer Drug Discovery and Development Adv. Exp. Med. Biol. 2008, 610, 19-42
3. Feng, S. S.; Chien, S. Chemotherapeutic Engineering: Application and Further Development of Chemical Engineering Principles for Chemotherapy of Cancer and other Diseases Chem. Eng. Sci. 2003, 58, 4087-4114
4. Feng, S. S.; Zhao, L. Y.; Zhang, Z. P.; Bhakta, G.; Win, K. Y.; Dong, Y.C. Chemotherapeutic Engineering: Vitamin E TPGS-Emulsified Nanoparticles of Biodegradable Polymers Realized Sustainable Paclitaxel Chemotherapy for 168 h In Vivo Chem. Eng. Sci. 2007, 62, 6641-6648
5. Petros, R. A.; DeSimone, J. M. Strategies in the Design of Nanoparticles for Therapeutic Applications Nat. Rev. Drug. Discovery 2010, 9, 615-627
6. Jia, J.; Zhu, F.; Ma, X. H.; Cao, Z. W. W.; Li, Y. X. X.; Chen, Y. Z. Mechanisms of Drug Combinations: Interaction and Network Perspectives Nat. Rev. Drug. Discovery 2009, 8, 111-128
7. Lehar, J.; Krueger, A. S.; Avery, W.; Heilbut, A. M.; Johansen, L. M.; Price, E. R. Synergistic Drug Combinations Tend to Improve Therapeutically Relevant Selectivity Nat. Biotechnol. 2009, 27, 659-666
8. Woodcock, J.; Griffin, J. P.; Behrman, R. E. Development of Novel Combination Therapies New. Engl. J. Med. 2011, 364, 985-997
9. Mitsiades, C. S.; Davies, F. E.; Laubach, J. P.; Joshua, D.; Miguel, J. S.; Anderson, K. C. Future Directions of Next-Generation Novel Therapies, Combination Approaches, and the Development of Personalized Medicine in Myeloma J. Clin. Oncol. 2011, 29, 1916-1923
10. Mi, Y.; Liu, Y. T.; Guo, Y. J.; Feng, S. S. Herceptin (R)-Conjugated Nanocarriers for Targeted Imaging and Treatment of HER2-Positive Cancer Nanomedicine (London, U.K.) 2011, 6, 311-322
11. Mi, Y.; Li, K.; Liu, Y.; Pu, K. Y.; Liu, B.; Feng, S. S. Herceptin Functionalized Polyhedral Oligomeric Silsesquioxanee Conjugated Oligomersesilica/Iron Oxide Nanoparticles for Tumor Cell Sorting and Detection Biomaterials 2011, 32, 8226-8233
12. Esteva, F. J.; Valero, V.; Pusztai, L.; Boehnke-Michaud, L.; Buzdar, A. U.; Hortobagyi, G. N. Chemotherapy of Metastatic Breast Cancer: What to Expect in 2001 and Beyond Oncologist 2001, 6, 133-146
13. Bullock, K.; Blackwell, K. Clinical Efficacy of Taxane-Trastuzumab Combination Regimens for HER-2-Positive Metastatic Breast Cancer Oncologist 2008, 13, 515-525
14. Joensuu, H.; Lehtinen, P. K.; Bono, P.; Alanko, T.; Kataja, V.; Asola, R. Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer New. Engl. J. Med. 2006, 354, 809-820
15. Baselga, J.; Cortes, J.; Kim, S. B.; Im, S. A.; Hegg, R.; Im, Y. H. Pertuzumab Plus Trastuzumab Plus Docetaxel for Metastatic Breast Cancer N. Engl. J. Med. 2012, 366, 109-119
16. Sullivan, S. P.; Murthy, N.; Prausnitz, M. R. Minimally Invasive Protein Delivery with Rapidly Dissolving Polymer Microneedles Adv. Mater. (Weinheim, Ger.) 2008, 20, 933-938
17. Park, J. H.; Allen, M. G.; Prausnitz, M. R. Biodegradable Polymer Microneedles: Fabrication, Mechanics and Transdermal Drug Delivery J. Controlled Release 2005, 104, 51-66
18. Aoyagi, S.; Izumi, H.; Fukuda, M. Biodegradable Polymer Needle with Various Tip Angles and Consideration on Insertion Mechanism of Mosquito's Proboscis Sens. Actuators, A 2008, 143, 20-38
19. Kolli, C.S.; Banga, A. K. Characterization of Solid Maltose Micro Needles and their Use for Transdermal Delivery Pharm. Res. 2008, 25, 104-113
20. Donnelly, R. F.; Majithiya, R.; Singh, T. R.; Morrow, D. I.; Garland, M. J.; Demir, Y. K. Design, Optimization and Characterisation of Polymeric Microneedle Arrays Prepared by a Novel Laser-based Micromoulding Technique Pharm. Res. 2011, 28, 41-57
21. Matsumoto, A.; Matsukawa, Y.; Suzuki, T.; Yoshino, H. Drug Release Characteristics of Multi-Reservoir Type Microspheres with Poly (dl -lactide- co -glycolide) and poly(dl -lactide) J. Controlled Release 2005, 106, 172-180
22. Lee, J. W.; Park, J. H.; Prausnitz, M. R. Dissolving Microneedles for Transdermal Drug Delivery Biomaterials 2008, 29, 2113-2124
23. Chu, L.Y.; Choi, S. O.; Prausnitz, M. R. Fabrication of Dissolving Polymer Microneedles for Controlled Drug Encapsulation and Delivery: Bubble and Pedestal Microneedle Designs J. Pharm. Sci. 2010, 99, 4228-4238
24. Langer, R. Drug Delivery and Targeting Nature 1998, 392, 5-10
25. Maeda, H.; Wu, J.; Sawa, T.; Matsumura, Y.; Hori, K. Tumor Vascular Permeability and the EPR Effect in Macromolecular Therapeutics: A Review J. Controlled Release 2000, 29, 271-284
26. Fox, M. E.; Szoka, F. C.; Fréchet, J. M. Soluble Polymer Carriers for the Treatment of Cancer: The Importance of Molecular Architecture Acc. Chem. Res. 2009, 42, 1141-1151
27. Duncan, R. The Dawning Era of Polymer Therapeutics Nat. Rev. Drug Discovery 2003, 2, 347-360
28. Davis, M. E.; Chen, Z.; Shin, D. M. Nanoparticle Therapeutics: An Emerging Treatment Modality for Cancer Nat. Rev. Drug Discovery 2008, 7, 771-782
29. Win, K. Y.; Feng, S. S. Effects of Particle Size and Surface Coating on Cellular Uptake of Polymeric Nanoparticles for Oral Delivery of Anticancer Drugs Biomaterials 2005, 26, 2713-2722
30. Sun, B.; Ranganathan, B.; Feng, S. Multifunctional Poly(d, l -lactide- co -glycolide)/Montmorillonite (PLGA/MMT) Nanoparticles Decorated by Trastuzumab for Targeted Chemotherapy of Breast Cancer Biomaterials 2008, 29, 475-486
31. Prabha, S.; Labhasetwar, V. Critical Determinants in PLGA/PLA Nanoparticle Mediated Gene Expression Pharm. Res. 2004, 21, 354-364
32. Vivek, R.; Nipun Babu, V.; Thangam, R.; Subramanian, K. S.; Kannan, S. pH-Responsive Drug Delivery of Chitosan Nanoparticles as Tamoxifen Carriers for Effective Anti-Tumor Activity in Breast Cancer Cells Colloids Surf., B 2013, 111, 117-123
33. Wang, F.; Wang, Y. C.; Dou, S.; Xiong, M. H.; Sun, T. M.; Wang, J. Doxorubicin-Tethered Responsive Gold Nanoparticles Facilitate Intracellular Drug Delivery for Overcoming Multidrug Resistance in Cancer Cells ACS Nano 2011, 5, 3679-3692
34. Panyam, J.; Zhou, W. Z.; Prabha, S.; Sahoo, S. K.; Labhasetwar, V. Rapid Endo-Lysosomal Escape of Poly(dl -lactide- co -glycolide) Nanoparticles: Implications for Drug and Gene Delivery FASEB J. 2002, 16, 1217-1226
35. Hu, X.; Tian, J.; Liu, T.; Zhang, G.; Liu, S. Photo-Triggered Release of Caged Camptothecin Prodrug from Dually Responsive Shell Cross-Linked Micelles Macromolecules 2013, 46, 6243-6256
36. Zhao, J.; Mi, Y.; Liu, Y. T.; Feng, S. S. Quantitative Control of Targeting Effect of Anticancer Drugs Formulated by Ligand-Conjugated Nanoparticles of Biodegradable Copolymer Blend Biomaterials 2012, 33, 1948-1958
37. Mi, Y.; Liu, X. L.; Zhao, J.; Ding, J.; Feng, S. S. Multimodality Treatment of Cancer with Herceptin Conjugated, Thermomagnetic Iron Oxides and Docetaxel Loaded Nanoparticles of Biodegradable Polymers Biomaterials 2012, 33, 7519-7529
38. Jin, C.; Qian, N.; Zhao, W.; Yang, W.; Bai, L.; Wu, H.; Wang, M.; Song, W.; Dou, K. Improved Therapeutic Effect of DOX-PLGA-PEG Micelles Decorated with Bivalent Fragment HAb18 F(ab′) (2) for Hepatocellular Carcinoma Biomacromolecules 2010, 11, 2422-2431
39. Avgoustakis, K.; Beletsi, A.; Panagi, Z.; Klepetsanis, P.; Livaniou, E.; Evangelatos, G.; Ithakissios, D. S. Effect of Copolymer Composition on the Physicochemical Characteristics, In Vitro Stability, and Biodistribution of PLGA-mPEG Nanoparticles Int. J. Pharm. (Amsterdam, Neth.) 2003, 259, 115-127
40. Kocbek, P.; Obermajer, N.; Cegnar, M.; Kos, J.; Kristl, J. Targeting Cancer Cells Using PLGA Nanoparticles Surface Modified with Monoclonal Antibody J. Controlled Release 2007, 120, 18-26
41. Primard, C.; Poecheim, J.; Heuking, S.; Sublet, E.; Esmaeili, F.; Borchard, G. Multifunctional PLGA-Based Nanoparticles Encapsulating Simultaneously Hydrophilic Antigen and Hydrophobic Immunomodulator for Mucosal Immunization Mol. Pharmaceutics 2013, 10, 2996-3004
42. Mosmann, T. Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays J. Immunol. Methods 1983, 65, 55-63
43. Gulfam, M.; Kim, J.E.; Lee, J. M.; Ku, B.; Chung, B. H.; Chung, B. G. Anticancer Drug-Loaded Gliadin Nanoparticles Induce Apoptosis in Breast Cancer Cells Langmuir 2012, 28, 8216-8223
44. Liang, C.; Yang, Y.; Ling, Y.; Huang, Y.; Li, T.; Li, X. Improved Therapeutic Effect of Folate-Decorated PLGA-PEG Nanoparticles for Endometrial Carcinoma Bioorg. Med. Chem. 2011, 19, 4057-4066
45. Chaudhari, R.; Kumar, A. K.; Khandelwal, V. K. M; Ukawala, M.; Manjappa, A.S.; Mishra, A. K.; Monkkonen, J.; Murthy, R. S. R. Bone Metastasis Targeting: A Novel Approach to Reach Bone Using Zoledronate Anchored PLGA Nanoparticle as Carrier System Loaded with Docetaxel J. Controlled Release 2012, 158, 470-478
46. Zhao, S.; Tan, S.; Guo, Y.; Huang, J.; Chu, M.; Liu, H.; Zhang, Z. pH-sensitive Docetaxel-Loaded TPGS-poly(β-Amino ester) Copolymer Nanoparticles for Overcoming Multidrug Resistance Biomacromolecules 2013, 14, 2636-2646
47. Zhao, J.; Mi, Y.; Feng, S. S. Targeted Co-Delivery of Docetaxel and siPlk1 by Herceptin-Conjugated Vitamin E TPGS Based Immunomicelles Biomaterials 2013, 34, 3411-3421